← Back to patent-cliff list

Fosnetupitant

Tier C — Watch / trade

Fosnetupitant

Helsinn
Originator
2022
First approval
-
Expiry (public)
$0.04B ▲
Peak sales
Small molecule
Type

Targets:NK1R

Brand:Arokaris

Indications (approved):Chemotherapy-induced nausea and vomiting

Regional status

US
-
EU
-
China
-
Japan
Approved
2022-03-28

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 15 · Total yield 15 g
FOSNE-007342417-01-0FOSNE-008290297-24-4FOSNE-009342417-02-1FOSNE-010290297-25-5FOSNE-011289686-69-7FOSNE-012290297-26-6FOSNE-013229625-50-7FOSNE-0141703749-32-9FOSNE-015289686-70-0FOSNE-01613086-84-5FOSNE-01733494-80-3FOSNE-01833494-81-4FOSNE-01934075-24-6Fosnetupitant—FOSNE-0015326-23-8FOSNE-00233872-80-9FOSNE-003342416-99-3FOSNE-004—FOSNE-005342417-00-9FOSNE-006109-01-3API · Fosnetupitant
CodeCAS No.Intermediate
FOSNE-007342417-01-06-(4-methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide
FOSNE-008290297-24-4-
FOSNE-009342417-02-1methyl (6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)carbamate
FOSNE-010290297-25-5N-methyl-6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-amine
FOSNE-011289686-69-7Available2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoyl chloride
FOSNE-012290297-26-6-
FOSNE-013229625-50-7Availabledi-tert-butyl (chloromethyl) phosphate
FOSNE-0141703749-32-9-
FOSNE-015289686-70-0Available2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoic acid
FOSNE-01613086-84-5-
FOSNE-01733494-80-3-
FOSNE-01833494-81-4-
FOSNE-01934075-24-6-
Fosnetupitant--
FOSNE-0015326-23-86-chloronicotinic acid
FOSNE-00233872-80-9o-tolylmagnesium chloride
FOSNE-003342416-99-3-
FOSNE-004--
FOSNE-005342417-00-9-
FOSNE-006109-01-3Available1-methylpiperazine

Frequently asked questions

What are the approved indications of Fosnetupitant?

Approved indications include: Chemotherapy-induced nausea and vomiting.

When does the Fosnetupitant patent expire?

No public expiry year is available for Fosnetupitant yet; this page updates once verified.

How many synthesis routes are recorded for Fosnetupitant?

1 synthesis routes are recorded; the shortest is 15 steps with 15 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Fosnetupitant intermediates?

4 intermediate CAS of Fosnetupitant are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Fosnetupitant intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-22